BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1236 related articles for article (PubMed ID: 28100023)

  • 1. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype.
    Mann DMA; Snowden JS
    Brain Pathol; 2017 Nov; 27(6):723-736. PubMed ID: 28100023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations.
    Snowden JS; Adams J; Harris J; Thompson JC; Rollinson S; Richardson A; Jones M; Neary D; Mann DM; Pickering-Brown S
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):497-505. PubMed ID: 26473392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.
    Irwin DJ; Cairns NJ; Grossman M; McMillan CT; Lee EB; Van Deerlin VM; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2015 Apr; 129(4):469-91. PubMed ID: 25549971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.
    Hofmann JW; Seeley WW; Huang EJ
    Annu Rev Pathol; 2019 Jan; 14():469-495. PubMed ID: 30355151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontotemporal lobar degeneration: diversity of FTLD lesions.
    Seilhean D; Bielle F; Plu I; Duyckaerts C
    Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration.
    Davidson YS; Robinson AC; Flood L; Rollinson S; Benson BC; Asi YT; Richardson A; Jones M; Snowden JS; Pickering-Brown S; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Jun; 5(1):54. PubMed ID: 28666471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion.
    Bieniek KF; Murray ME; Rutherford NJ; Castanedes-Casey M; DeJesus-Hernandez M; Liesinger AM; Baker MC; Boylan KB; Rademakers R; Dickson DW
    Acta Neuropathol; 2013 Feb; 125(2):289-302. PubMed ID: 23053135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.
    Davidson YS; Flood L; Robinson AC; Nihei Y; Mori K; Rollinson S; Richardson A; Benson BC; Jones M; Snowden JS; Pickering-Brown S; Haass C; Lashley T; Mann DMA
    Acta Neuropathol Commun; 2017 Apr; 5(1):31. PubMed ID: 28431575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontotemporal lobar degeneration and amyotrophic lateral sclerosis: molecular similarities and differences.
    Neumann M
    Rev Neurol (Paris); 2013 Oct; 169(10):793-8. PubMed ID: 24011641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontotemporal Lobar Degeneration.
    Premi E; Padovani A; Borroni B
    Adv Exp Med Biol; 2012; 724():114-27. PubMed ID: 22411238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progranulin and TDP-43: mechanistic links and future directions.
    Kumar-Singh S
    J Mol Neurosci; 2011 Nov; 45(3):561-73. PubMed ID: 21863317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration.
    Hortobágyi T; Cairns NJ
    Handb Clin Neurol; 2017; 145():369-381. PubMed ID: 28987183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progressive nonfluent aphasia].
    Murayama S; Saito Y
    Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of frontotemporal lobar degeneration: an up-date and diagnosis algorithm.
    Le Ber I
    Rev Neurol (Paris); 2013 Oct; 169(10):811-9. PubMed ID: 24011980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No interaction between tau and TDP-43 pathologies in either frontotemporal lobar degeneration or motor neurone disease.
    Robinson AC; Thompson JC; Weedon L; Rollinson S; Pickering-Brown S; Snowden JS; Davidson YS; Mann DM
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):844-54. PubMed ID: 24861427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the genetics of the ALS-FTLD complex.
    Morris HR; Waite AJ; Williams NM; Neal JW; Blake DJ
    Curr Neurol Neurosci Rep; 2012 Jun; 12(3):243-50. PubMed ID: 22477152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical iron accumulation in MAPT- and C9orf 72-associated frontotemporal lobar degeneration.
    Giannini LAA; Bulk M; Kenkhuis B; Rajicic A; Melhem S; Hegeman-Kleinn I; Bossoni L; Suidgeest E; Dopper EGP; van Swieten JC; van der Weerd L; Seelaar H
    Brain Pathol; 2023 Jul; 33(4):e13158. PubMed ID: 36974379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heritability and genetics of frontotemporal lobar degeneration.
    Rohrer JD; Guerreiro R; Vandrovcova J; Uphill J; Reiman D; Beck J; Isaacs AM; Authier A; Ferrari R; Fox NC; Mackenzie IR; Warren JD; de Silva R; Holton J; Revesz T; Hardy J; Mead S; Rossor MN
    Neurology; 2009 Nov; 73(18):1451-6. PubMed ID: 19884572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant.
    King A; Al-Sarraj S; Troakes C; Smith BN; Maekawa S; Iovino M; Spillantini MG; Shaw CE
    Acta Neuropathol; 2013 Feb; 125(2):303-10. PubMed ID: 23053136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The molecular pathology of frontotemporal lobar degeneration].
    Fujishiro H; Hasegawa M; Arai T
    Seishin Shinkeigaku Zasshi; 2010; 112(4):313-24. PubMed ID: 20496755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.